RxDoctor Payments Data

Seyed Kalantar, MD

Orthopaedic Surgery · Washington, DCNPI 1801049721

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $567,112 of the $886,072 with a category attached, or 64.0%. 28 manufacturers reported payments, led by Innovasis Inc at 48.5% of the total. Reporting peaked in 2020 at $223,105 and has fallen 59.9% since, to $89,401 in 2025. Among orthopaedic surgery clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$886,072in general payments, 2019–2025

Across 514 payments — averaging $1723.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Innovasis Inc$430K
  • Globus Medical$221K
  • Precision Spine, Inc.$72K
  • Stryker$63K
  • Alphatec Spine, Inc$38K
  • VB Spine LLC$21K
  • plus $42K from 22 others
$21,058in ownership & investment interests, 2019–2025

Across 1 payment — averaging $21,058 each. An ownership or investment interest held by the physician or an immediate family member.

  • Restor3d, Inc.$21K

What the payments were for

  • Royalty or licence$211,43524%
  • Consulting fees$567,11264%
  • Speaking & faculty fees$21,8852%
  • Travel & lodging$63,5787%
  • Food & beverage$19,3682%
  • Gifts$440%
  • Entertainment$2,6500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$886,072 in reported general payments places this provider in the 95th percentile of 46 orthopaedic surgery providers in District of Columbia.

See all orthopaedic surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$585,183
Medicare patients
503
Services billed
1,378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib11$178
Methylprednisolone12$81
Meloxicam12$60

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →